Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Most Cited Paper
in Acute Myeloid Leukemia Research
18 Months Post-Publication
Class of 2026
“Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
Acute myeloid leukemia (AML) · allogeneic haematopoietic stem cell transplantation · high-dose cytarabine · salvage chemotherapy · mitoxantrone · Induction chemotherapy · watchful waiting · disease control · non-inferiority trial · Complete remission (CR) · Relapsed AML · poor responsive acute myeloid leukaemia · intensive conditioning · Treatment response · non-favourable-risk acute myeloid leukaemia · treatment-related complications · progressive acute myeloid leukaemia · intention-to-transplant
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026. Accessed 2026-07-31. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459